Pentoxifylline preferentially inhibits interleukin-10 production by HIV-1-infected human T cells.
Navarro
J
J
Pizarro
A
A
Fernández-Cruz
E
E
Fresno
M
M
Muñoz-Fernández
M A
MA
D000328:Adult; D002478:Cells, Cultured; D004305:Dose-Response Relationship, Drug; D015497:HIV-1 / Q000472:pathogenicity / Q000502:physiology*; D006801:Humans; D007371:Interferon-gamma / Q000096:biosynthesis; D016753:Interleukin-10 / Q000037:antagonists & inhibitors / Q000096:biosynthesis*; D010431:Pentoxifylline / Q000494:pharmacology*; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology* / Q000821:virology*; D014409:Tumor Necrosis Factor-alpha / Q000096:biosynthesis
D014409:Tumor Necrosis Factor-alpha; D016753:Interleukin-10; D007371:Interferon-gamma; D010431:Pentoxifylline